Jong Lee, Day Zero CEO (via Day Zero website)
Genomics + machine learning = company's strategy to speed up hospital diagnostics and identify antibiotic resistance
Day Zero Diagnostics has been focused on combining genome sequencing and machine learning to diagnose infectious diseases. And now the diagnostics player has netted its …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.